| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/17/2008 | CN100418518C Injectable diacetylamino acetic ethylenediamine prepn. preparing method and quality-control tech. therefor |
| 09/17/2008 | CN100418516C Preparation-at-use device comprising pre-formed hydrogel product |
| 09/17/2008 | CN100418515C Tooth whitening chewing gum |
| 09/17/2008 | CN100418514C Soft capsule with elslholtzia and method for preparing same |
| 09/17/2008 | CN100418513C Standby agent for treating burns |
| 09/17/2008 | CN100418512C 'Shengmai' infusion and its preparation process |
| 09/16/2008 | US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 09/16/2008 | US7425582 Stabilized dispersions comprising excipient surface-modified organic nanoparticles and medicament particles |
| 09/16/2008 | US7425581 Temperature sensitive polymers |
| 09/16/2008 | US7425543 Microencapsulated materials and method of making same |
| 09/16/2008 | US7425528 Stabilization of granules |
| 09/16/2008 | US7425342 For reducing blood cholesterol in patients |
| 09/16/2008 | US7425341 granulating a mixture of compressible water soluble carbohydrates, compressible water insoluble fillers, ondansetron and solvents, drying, mixing with disintegrants, lubricants, surfactants, flavors, sweeteners and colorants, and compressing to form tablets, that form suspensions, slurries or dispersions |
| 09/16/2008 | US7425340 a mixture of antispasmodic agents and carriers comprising urea compounds for intensifying permeability through the skin or mucous membranes, used for treating incontinence; side effect reduction |
| 09/16/2008 | US7425322 Responsive biomedical composites |
| 09/16/2008 | US7425319 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | US7425210 Drug delivery system for implantable medical device |
| 09/16/2008 | CA2505128C Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/16/2008 | CA2472031C Medical device with coating that promotes endothelial cell adherence and differentiation |
| 09/16/2008 | CA2468537C Process for making pre-formed objects |
| 09/16/2008 | CA2447519C Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 09/16/2008 | CA2414349C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 09/16/2008 | CA2403949C Transdermal therapeutic system for the delivery of lerisetron |
| 09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
| 09/16/2008 | CA2384448C Method of treatment of seborrheic dermatitis |
| 09/16/2008 | CA2378503C Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation |
| 09/16/2008 | CA2346062C Coated medicament forms with controlled active substance release |
| 09/16/2008 | CA2339290C Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 09/16/2008 | CA2337152C Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 09/16/2008 | CA2331414C Transdermal therapeutic system for the administration of candesartan |
| 09/16/2008 | CA2322315C Fast disintegrating tablets |
| 09/16/2008 | CA2273017C Local administration device for solid or semi-solid formulations, time-release formulations for parenteral administration and their method of preparation |
| 09/16/2008 | CA2215378C Diltiazem controlled release formulation |
| 09/16/2008 | CA2195633C Blood-pool imaging compositions use and method |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/16/2008 | CA2166062C The use of non-ionic surfactants in stable topical retinoid compositions |
| 09/16/2008 | CA2110730C Sustained-release preparation |
| 09/15/2008 | CA2624573A1 Method of obtaining vegetable proteins and/or peptides, proteins produced according to said method and/or peptides and use thereof |
| 09/12/2008 | WO2008109832A2 Viable near-infrared fluorochrome labeled cells and methods of making and using same |
| 09/12/2008 | WO2008109806A2 Electrostatic coating of particles for drug delivery |
| 09/12/2008 | WO2008109723A1 Pharmaceutical analysis apparatus and method |
| 09/12/2008 | WO2008109712A2 Nanoparticle delivery systems for membrane-integrating peptides |
| 09/12/2008 | WO2008109616A1 Hemorrhoid treatment suppository |
| 09/12/2008 | WO2008109462A2 Sustained release pellets comprising wax-like material |
| 09/12/2008 | WO2008109427A2 Anesthetic spray composition |
| 09/12/2008 | WO2008109424A1 Composition, therapy and device for treatment of nail infections |
| 09/12/2008 | WO2008109407A2 Extracellular matrix-derived gels and related methods |
| 09/12/2008 | WO2008109385A2 Oral administration of a calcitonin |
| 09/12/2008 | WO2008109230A2 Therapeutic composition with enhanced endothelium targeting |
| 09/12/2008 | WO2008109170A1 Pharmaceutical composition comprising candesartan cilexetil |
| 09/12/2008 | WO2008109163A1 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 09/12/2008 | WO2008109124A1 Use of nitroglycerin to reverse local anesthesia |
| 09/12/2008 | WO2008109119A2 Wnt compositions and methods of use thereof |
| 09/12/2008 | WO2008109095A1 Sulfone polymer compositions |
| 09/12/2008 | WO2008109031A2 Liposome carriers for in vivo delivery of fullerenes |
| 09/12/2008 | WO2008109018A1 Compositions comprising carisoprodol and methods of use thereof |
| 09/12/2008 | WO2008108940A1 Fast-dissolving/disintegrating film preparation having high proportion of active |
| 09/12/2008 | WO2008108862A2 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery |
| 09/12/2008 | WO2008108776A1 Compositions and methods for treating b- cell malignancies |
| 09/12/2008 | WO2008108736A1 Particles for delivery of bioactive factors |
| 09/12/2008 | WO2008108424A1 Device for the transdermal administration of bisoprolol |
| 09/12/2008 | WO2008108324A1 Process for producing vesicle, vesicle obtained by the process, and process for producing frozen particle for use in vesicle production |
| 09/12/2008 | WO2008108286A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 09/12/2008 | WO2008108209A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 09/12/2008 | WO2008107908A1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
| 09/12/2008 | WO2008107746A2 Tablet comprising microorganisms and a combination of excipients and the manufacture process thereof |
| 09/12/2008 | WO2008107729A1 Sustained release bionanocomposites, a process for producing the same and use thereof |
| 09/12/2008 | WO2008107452A1 Pharmaceutical composition comprising a salt of rosiglitazone |
| 09/12/2008 | WO2008107410A1 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids |
| 09/12/2008 | WO2008107390A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/12/2008 | WO2008107384A1 Dehydrated granular composition and biomedical applications thereof |
| 09/12/2008 | WO2008107301A2 Rapid-disintegration monolayer film for the oral administration of active substances |
| 09/12/2008 | WO2008107197A2 Nutrient compositions |
| 09/12/2008 | WO2008107193A1 Topical composition comprising retinoid receptor agonist for treatment of acne |
| 09/12/2008 | WO2008107179A1 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion |
| 09/12/2008 | WO2008107149A2 Pharmaceutical form with impeded abuse |
| 09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
| 09/12/2008 | WO2008106901A1 A pharmaceutical composition with atorvastatin active ingredient |
| 09/12/2008 | WO2008106787A1 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same |
| 09/12/2008 | WO2008106772A1 Phospholipid compositions with improved bioavailability and methods for their use |
| 09/12/2008 | WO2008091957A3 Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| 09/12/2008 | WO2008087606A3 Composition and method of stabilized sensitive ingredient |
| 09/12/2008 | WO2008087605A3 Composition and method of stabilized sensitive ingredient |
| 09/12/2008 | WO2008087140A3 Liquid formulations containing a carotinoid |
| 09/12/2008 | WO2008085997A3 Vegetarian microcapsules |
| 09/12/2008 | WO2008079818A3 Intravenous administration of water soluble analgesic formulations |
| 09/12/2008 | WO2008079543A9 Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces |
| 09/12/2008 | WO2008077813A3 Orally disintegrating tablets |
| 09/12/2008 | WO2008072952A3 Anti-inflammatory compounds containing compositions for treatment of cancer |
| 09/12/2008 | WO2008069941A3 Modified release ibuprofen solid oral dosage form |
| 09/12/2008 | WO2008065107A8 Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film |
| 09/12/2008 | WO2008060964A3 Unit dosage package and methods for administering weight loss medications |
| 09/12/2008 | WO2008060934A3 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 09/12/2008 | WO2008059522B1 Herbal gastrointenstinal controlled drug delivery dosage forms including pellets and process for their preparation |
| 09/12/2008 | WO2008051363A3 Stable polypeptide formulations |
| 09/12/2008 | WO2008050188A3 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 09/12/2008 | WO2008037224A3 Controlled release dosage form containing lercanidipine and a performance enhancing acid |
| 09/12/2008 | WO2008033023A3 Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture |